arrow
R

Rishi S. Kotecha

Perth Children's Hospital
H指数:28
被引数:2,814

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A real-world multi-institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B-cell acute lymphoblastic leukaemia

多机构真实世界经验:伊诺妥珠单抗标准剂量与替代剂量方案治疗复发/难治性儿童B细胞急性淋巴细胞白血病的比较

2026-10-220
PRE
Characteristics and outcome of T-cell/histiocyte-rich large B-cell lymphoma in childhood and adolescence: An international retrospective analysis

儿童和青少年T细胞/组织细胞丰富型大B细胞淋巴瘤的特征与预后:一项国际回顾性分析

2026-09-050
PRE
BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia

BCL-2和MCL1协同抑制增强了婴儿KMT2A重排急性淋巴细胞白血病的糖皮质激素疗法在临床前模型中的作用

2026-06-050
OA
IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors

IRS4是PI3K激活型癌症依赖基因,通过DNA重排或表观遗传机制在多种实体瘤中上调

2026-04-290
OA
Profiling histone post-translational modifications to identify signatures of epigenetic drug response in T-cell acute lymphoblastic leukemia

分析组蛋白翻译后修饰以识别T细胞急性淋巴细胞白血病中表观遗传药物反应的特征。

2026-03-260
OAAI
AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.

年龄适宜的儿童脑肿瘤模型揭示了年龄对肿瘤-免疫相互作用的影响。

2025-10-010
OAAI
Age-Based Pegaspargase Dosing is Safe and Achieves Therapeutic Levels in Infants with ALL: Report from COG AALL15P1

基于年龄的培门冬酶剂量给药在婴儿急性淋巴细胞白血病中是安全的,并能达到治疗性水平:COG AALL15P1研究报告

2025-09-260
OAAI
Returning raw genomic data to research participants in a pediatric cancer precision medicine trial (vol 10, 12, 2025)

在儿科癌症精准医学试验(第10卷,第12期,2025年)中向研究参与者返还原始基因组数据

2025-03-240
OA